Healthcare provider profile · identity verified

William Duong, M.D.

Allopathic & Osteopathic Physicians|Surgery|Vascular Surgery · LOMA LINDA, CA · NPI 1427402445

Profile state: payments only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

CMS Open Payments records show William Duong, M.D. received $16,082.80 in general payments during 2025 across 60 reported records.

Medtronic, Inc. accounted for 90.4% of that reported general-payment amount.

The Open Payments records used for this analysis explicitly named 33 associated products.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

$16,082.80

60 reported records · 14 companies

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Who paid this doctor?

Companies in 2025 General Payments

Reported companyCanonical companyAmountShareRecordsYear
Medtronic, Inc. Medtronic, Inc.
exact · evidence 2025-07-22
$14,542.0790.4%272025
Integra LifeSciences Corporation Unresolved — no canonical attribution shown $487.063.0%82025
Boston Scientific Corporation Unresolved — no canonical attribution shown $403.002.5%72025
Acera Surgical, Inc. Unresolved — no canonical attribution shown $184.741.1%12025
W. L. Gore & Associates, Inc. Unresolved — no canonical attribution shown $86.910.5%32025
Terumo Medical Corporation Unresolved — no canonical attribution shown $68.480.4%32025
Cook Medical LLC Unresolved — no canonical attribution shown $62.290.4%32025
Penumbra, Inc. Unresolved — no canonical attribution shown $61.040.4%12025
Imperative Care, Inc Unresolved — no canonical attribution shown $46.170.3%22025
Innovation Technologies Inc Unresolved — no canonical attribution shown $43.670.3%12025
Philips North America LLC Unresolved — no canonical attribution shown $35.230.2%12025
Stryker Corporation Unresolved — no canonical attribution shown $23.180.1%12025
Artivion, Inc. Unresolved — no canonical attribution shown $21.710.1%12025
Bolton Medical Inc Unresolved — no canonical attribution shown $17.250.1%12025

What were the payments for?

Payment categories

CategoryAmountRecords
Travel and Lodging$13,988.6911
Food and Beverage$1,689.2647
Long term medical supply or device loan$404.852

A meal, consulting fee, royalty, and travel payment describe different kinds of reported relationships and should not be interpreted as equivalent.

Analysis 1 · Payment-linked products

Products named in Open Payments records

Reported productTypeReported companyRelated amount*RecordsYear
ENDURANT IIS
Normalized: endurant iis
Device Medtronic, Inc. $14,251.76 22 2025
Source payment records
Ranger
Normalized: ranger
Device Boston Scientific Corporation $285.77 4 2025
Source payment records
MicroMatrix
Normalized: micromatrix
Device Integra LifeSciences Corporation $245.39 1 2025
Source payment records
Restrata Wound Matrix
Normalized: restrata wound matrix
Device Acera Surgical, Inc. $184.74 1 2025
Source payment records
Cytal
Normalized: cytal
Device Integra LifeSciences Corporation $159.46 1 2025
Source payment records
AngioJet Ultra 5000A
Normalized: angiojet ultra 5000a
Device Boston Scientific Corporation $92.03 2 2025
Source payment records
Integra
Normalized: integra
Device Integra LifeSciences Corporation $82.21 6 2025
Source payment records
Integra Dermal Regeneration Template
Normalized: integra dermal regeneration template
Device Integra LifeSciences Corporation $82.21 6 2025
Source payment records
PRIMATRIX
Normalized: primatrix
Device Integra LifeSciences Corporation $82.21 6 2025
Source payment records
Penumbra System
Normalized: penumbra system
Device Penumbra, Inc. $61.04 1 2025
Source payment records
AZUR CX DETACHABLE
Normalized: azur cx detachable
Device Terumo Medical Corporation $44.33 2 2025
Source payment records
IRRISEPT
Normalized: irrisept
Device Innovation Technologies Inc $43.67 1 2025
Source payment records
GORE PROPATEN Vascular Graft Pediatric Shunt
Normalized: gore propaten vascular graft pediatric shunt
Device W. L. Gore & Associates, Inc. $42.27 1 2025
Source payment records
Other Rental
Normalized: other rental
Device Philips North America LLC $35.23 1 2025
Source payment records
SYMPHONY CATHETER
Normalized: symphony catheter
Device Imperative Care, Inc $28.82 1 2025
Source payment records
GORE EXCLUDER Thoracoabdominal Branch Endoprosthesis
Normalized: gore excluder thoracoabdominal branch endoprosthesis
Device W. L. Gore & Associates, Inc. $26.48 1 2025
Source payment records
ROSEN
Normalized: rosen
Device Cook Medical LLC $25.93 1 2025
Source payment records
JETSTREAM SC
Normalized: jetstream sc
Device Boston Scientific Corporation $25.20 1 2025
Source payment records
VIANCE
Normalized: viance
Device Medtronic, Inc. $25.00 1 2025
Source payment records
VALIANT CAPTIVIA
Normalized: valiant captivia
Device Medtronic, Inc. $24.63 1 2025
Source payment records
ANGIO-SEAL
Normalized: angio seal
Device Terumo Medical Corporation $24.15 1 2025
Source payment records
IN.PACT ADMIRAL
Normalized: in pact admiral
Device Medtronic, Inc. $23.68 1 2025
Source payment records
CT THROMBECTOMY SYSTEM KIT
Normalized: ct thrombectomy system kit
Device Stryker Corporation $23.18 1 2025
Source payment records
FLOWTRIEVER CATHETER, S
Normalized: flowtriever catheter s
Device Stryker Corporation $23.18 1 2025
Source payment records
PHOTOFIX DECELLULARIZED BOVINE PERICARDIUM
Normalized: photofix decellularized bovine pericardium
Device Artivion, Inc. $21.71 1 2025
Source payment records
Vascular
Normalized: vascular
Device Artivion, Inc. $21.71 1 2025
Source payment records
COOK
Normalized: cook
Device Cook Medical LLC $18.35 1 2025
Source payment records
EXCLUDER Conformable AAA Endoprosthesis with Active Control
Normalized: excluder conformable aaa endoprosthesis with active control
Device W. L. Gore & Associates, Inc. $18.16 1 2025
Source payment records
ZENITH SPIRAL-Z
Normalized: zenith spiral z
Device Cook Medical LLC $18.01 1 2025
Source payment records
PRODIGY CATHETER
Normalized: prodigy catheter
Device Imperative Care, Inc $17.35 1 2025
Source payment records
RELAY THORACIC STENT-GRAFT WITH PLUS DELIVERY SYSTEM
Normalized: relay thoracic stent graft with plus delivery system
Device Bolton Medical Inc $17.25 1 2025
Source payment records
TREO ABDOMINAL STENT-GRAFT SYSTEM
Normalized: treo abdominal stent graft system
Device Bolton Medical Inc $17.25 1 2025
Source payment records
HAWKONE
Normalized: hawkone
Device Medtronic, Inc. $14.40 1 2025
Source payment records

* Product-associated amounts are non-additive because one payment record may name more than one product.

These products were named on specific Open Payments records. A named product does not show that the payment influenced treatment or prescribing.

Public prescribing for products named in payments

No exact normalized or approved-alias overlap was found in the loaded Part D year. This does not mean the doctor never prescribed the product.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

No publishable same-company prescribing overlap was found in the loaded Part D year. This does not mean the doctor never prescribed a drug reported elsewhere by a paying company.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

YearGeneral PaymentsMain payerExplicit productsCompany overlapsPart D coverage
2025 $16,082.80 · 60 records Medtronic, Inc. ANGIO-SEAL, AZUR CX DETACHABLE, AngioJet Ultra 5000A, COOK, CT THROMBECTOMY SYSTEM KIT, Cytal, ENDURANT IIS, EXCLUDER Conformable AAA Endoprosthesis with Active Control, FLOWTRIEVER CATHETER, S, GORE EXCLUDER Thoracoabdominal Branch Endoprosthesis, GORE PROPATEN Vascular Graft Pediatric Shunt, HAWKONE, IN.PACT ADMIRAL, IRRISEPT, Integra, Integra Dermal Regeneration Template, JETSTREAM SC, MicroMatrix, Other Rental, PHOTOFIX DECELLULARIZED BOVINE PERICARDIUM, PRIMATRIX, PRODIGY CATHETER, Penumbra System, RELAY THORACIC STENT-GRAFT WITH PLUS DELIVERY SYSTEM, ROSEN, Ranger, Restrata Wound Matrix, SYMPHONY CATHETER, TREO ABDOMINAL STENT-GRAFT SYSTEM, VALIANT CAPTIVIA, VIANCE, Vascular, ZENITH SPIRAL-Z
2024 Complete

Questions to ask

Questions you could discuss with your doctor

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Loaded source releases

DatasetYearPublicationSource
CMS Open Payments — General Payments 2025 2026-06-30 Original source
Medicare Part D Prescribers by Provider and Drug 2024 2026-05-06 Original source
NPPES Data Dissemination V2 current / reference data 2026-08-10 Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error